Press Releases

WHITTIER, Calif., Dec. 23, 2019 /PRNewswire/ -- PIH Health today announced that Good Samaritan Hospital, Los Angeles has officially joined its integrated healthcare network. This addition brings PIH Health to 7,100 full-time employees, three hospitals totaling 1,130 licensed beds, and 26 outpatient clinics.

BUCKHEAD, Ga., Dec. 23, 2019 /PRNewswire/ -- Advanced Gynecology is eager to serve the greater Atlanta community - now including Buckhead - with the best possible urogynecological care and top board-certified physicians. Employing the latest medical technologies and innovative practices, the team at Advanc

RESTON, Va., Dec. 23, 2019 /PRNewswire/ -- Leidos (NYSE: LDOS), Intel Corporation, and First Genesis today announced their collaborative approach in developing blockchain technologies to improve healthcare h

KING OF PRUSSIA, Pa., Dec. 23, 2019 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK, Dec. 23, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( "Liminal BioSciences" or the "Company"), is issuing this news release in light of unusual trading activity related to the common shares of the Company (the

SILVER SPRING, Md., Dec. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmo

CRANBURY, N.J., Dec. 23, 2019 /PRNewswire/ -- In a joint letter to the Center for Medicare and Medicaid Innovation (the Innovation Center), the Academy of Oncology Nurse & Patient Navigators (AONN+) and the National Navigation Roundtable (NNRT) commends the potential Oncology Care First (OCF) model, but shares concerns about its guidelines for patient navigation.

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for UBRELVY™ (ubrogepant) for the acute treatment of migraine with or without aura in adults. UBRELVY™ is the first and only orally-administered calcitonin gene-related peptide (CGR

SILVER SPRING, Md., Dec. 23, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcito

PROVIDENCE, R.I., Dec. 23, 2019 /PRNewswire/ -- EpiVax ("EpiVax, Inc.") continues its record-breaking performance and growth in personnel in 2019 while identifying new milestones to aspire to in 2020.